Clinical Trial Update: Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity [NA]

View source ↗

Summary

This clinical trial update reports on a study aimed at slowing cognitive decline in alpha-synucleinopathies through enhanced physical activity. The study, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University Hospital, Bonn | Conditions: Parkinson Disease, Prodromal Stage | NA | Status: RECRUITING